Paulson & Co. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$36,192,000
-16.3%
2,175,000
-43.7%
0.39%
-10.9%
Q2 2016$43,246,000
+31.7%
3,864,717
-1.6%
0.44%
+81.1%
Q1 2016$32,830,000
-10.6%
3,927,000
-0.5%
0.24%
+10.5%
Q4 2015$36,742,000
-17.5%
3,946,5000.0%0.22%
-4.8%
Q3 2015$44,517,000
-11.1%
3,946,5000.0%0.23%0.0%
Q2 2015$50,081,000
+36.3%
3,946,500
-0.1%
0.23%
+23.5%
Q1 2015$36,735,000
-29.2%
3,950,000
+9.0%
0.19%
-30.2%
Q4 2014$51,910,000
+53.9%
3,625,000
+11.5%
0.27%
+91.4%
Q3 2014$33,735,000
-34.8%
3,250,000
+1.6%
0.14%
-37.5%
Q2 2014$51,776,000
+128.8%
3,200,000
+129.8%
0.22%
+101.8%
Q1 2014$22,628,0001,392,5000.11%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders